4//SEC Filing
COFFMAN ROBERT 4
Accession 0001209191-19-012790
CIK 0001029142other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:31 PM ET
Size
15.5 KB
Accession
0001209191-19-012790
Insider Transaction Report
Form 4
COFFMAN ROBERT
Chief Scientific Officer & VP
Transactions
- Exercise/Conversion
Restricted Stock Unit
2019-02-22−8,500→ 8,500 totalExp: 2024-02-21→ Common Stock (8,500 underlying) - Exercise/Conversion
Common Stock
2019-02-22+8,500→ 140,970 total - Exercise/Conversion
Common Stock
2019-02-22+54,702→ 132,470 total - Exercise/Conversion
Restricted Stock Unit
2019-02-22−54,702→ 0 totalExp: 2024-02-21→ Common Stock (54,702 underlying) - Award
Restricted Stock Unit
2019-02-22+22,000→ 22,000 totalExp: 2026-02-21→ Common Stock (22,000 underlying) - Award
Stock Option (Right to Buy)
2019-02-22+88,000→ 88,000 totalExercise: $10.47Exp: 2026-02-21→ Common Stock (88,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock that vested and converted to common stock on February 22, 2019.
- [F2]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.
- [F3]Each RSU represents a right to receive one share of common stock. These RSUs vested upon completion of certain performance conditions.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001278710
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:31 PM ET
- Size
- 15.5 KB